The Satiety and Clinical Adiposity Liraglutide Evidence (SCALE) Obesity and Prediabetes randomized, double-blind, placebo-controlled trial of 3.0 mg of once daily liraglutide achieved a mean 8.4 kg weight loss in patients with obesity without T2DM [7]
Maintaining correct storage conditions for any injectable peptide medicine is essential to preserving its potency, safety, and structural integrity
Shah and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
This helps keep your blood sugar from climbing too high
She explains that liraglutide is less potent, on average, for weight loss than semaglutide or tirzepatide
Smith explained that while many prescriptions are for diabetes, the same companies have rebranded products specifically for weight loss, contributing to the demand